XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Jan. 31, 2020
Cash flows from operating activities:      
Net income/(loss) $ 92,559 $ (111,194) $ 42,379
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:      
Impairment of goodwill and intangible assets 0 155,919 0
Non-cash corporate initiatives (926) 3,722  
Change in contingent consideration 0 (0) (15,356)
Gain on sale of a non-operating asset 0 (1,317) 0
Depreciation and amortization 12,463 14,112 16,381
Transactional (gains)/losses (808) (836) 1,457
Provision for inventories and accounts receivable 4,795 3,786 3,152
Deferred income taxes (208) (18,292) 4,352
Stock-based compensation 4,952 5,089 6,373
Cost savings initiatives     (320)
Other 561 126 923
Changes in assets and liabilities:      
Trade receivables (18,550) 2,424 5,908
Inventories (15,436) 21,596 (5,549)
Other current assets 2,054 2,261 8,103
Income taxes receivable 17,089 (21,037) (7,394)
Accounts payable 18,269 (7,811) (3,642)
Accrued liabilities 1,368 4,480 (4,944)
Accrued payroll and benefits 7,263 11,344 (12,469)
Income taxes payable 1,430 2,142 (5,393)
Other non-current assets 3,258 1,323 (2,398)
Other non-current liabilities 681 573 507
Net cash provided by operating activities 130,814 68,410 32,070
Cash flows from investing activities:      
Capital expenditures (5,656) (3,018) (12,713)
Long-term investments (1,967)    
Proceeds from sale of a non-operating asset   1,317 0
Trademarks and other intangibles (291) (164) (255)
Acquisitions, net of cash acquired     (639)
Proceeds from sale of an asset held for sale 0   240
Net cash used in investing activities (7,914) (1,865) (13,367)
Cash flows from financing activities:      
Repayments of bank borrowings (21,140) (64,465) 0
Proceeds from bank borrowings   30,879 0
Dividends paid (21,973) (18,400)
Stock repurchase (22,599) (4,199)
Distribution of noncontrolling interest earnings (1,230)    
Contributions from noncontrolling interest 298    
Stock awards and options exercised and other changes 324 (497) (1,266)
Debt issuance cost (294) (300) 0
Net cash (used in)/provided by financing activities (66,614) (34,383) (23,865)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (2,993) 5,823 1,141
Net increase (decrease) in cash, cash equivalents and restricted cash 53,293 37,985 (4,021)
Cash, cash equivalents and restricted cash at beginning of year 224,423 186,438 190,459
Cash, cash equivalents and restricted cash at end of year 277,716 224,423 186,438
Non-cash financing activities:      
Dividends declared but not paid   2,320 0
Reconciliation of cash, cash equivalents and restricted cash:      
Cash and cash equivalents 277,128 223,811 185,872
Restricted cash included in other non-current assets 588 612 566
Cash, cash equivalents, and restricted cash $ 277,716 $ 224,423 $ 186,438